North America Colorectal Procedure Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Endoscopes, Electrosurgery Devices, Handheld Devices & Visual Systems, Sealing & Stapling Devices, Ligation Clips and Dilators & Speculas, Cut

North America Colorectal Procedure Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Endoscopes, Electrosurgery Devices, Handheld Devices & Visual Systems, Sealing & Stapling Devices, Ligation Clips and Dilators & Speculas, Cutters and Shears, Accessories, and Others), Surgery Type (Right Hemicolectomy, Left Hemicolectomy, Subtotal Colectomy, Low Anterior Resection, Abdomino-Perineal Resection, and Others), End User (Hospitals & Clinics, Surgery Centers, and Others), and Indication (Colon Polyps, Crohn's Disease, Colorectal Cancer, Colitis, Irritable Bowel Syndrome, and Other Indications)

The North America colorectal procedure market is projected to grow from US$ 6,311.66 million in 2022 to US$ 12,946.28 million by 2028. It is estimated to grow at a CAGR of 12.7% from 2022 to 2028.

Increasing Prevalence of Colorectal Cancer Bolsters North America Colorectal Procedure Market

Colorectal cancer is one of the most lethal cancer types developed in individuals with the combined influence of genetic and environmental factors. According to the World Health Organization (WHO), colorectal cancer is the third most prevalent form of cancer; it is the third most common cancer in men and the second most common cancer in women. The lifetime risk of developing colorectal cancer is about 1 in 23 for men and 1 in 25 for women. A significant population in North America is diagnosed with colorectal cancer. For instance, according to the Centers for Disease Control and Prevention (CDC) and American Cancer Society, ~1.93 million cases of adults in the US were diagnosed with colon and rectum cancer, and 53,200 deaths were reported with colorectal cancer in 2020. These statistics indicate increased demand for advanced cancer diagnostics and therapeutics in North America, which is boosting the growth of the colorectal procedure market in the region.

Market Overview



The North America colorectal procedure market is segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the growing commonness of age-related medical conditions and continuous improvements in technologies in the region with increasing government funds. Moreover, the rising incidence of colorectal cancer and growing government support for research in colon cancer are contributing to the market growth. Colorectal cancer is among the five most common cancers diagnosed in the US. According to the estimates from the American Cancer Society, ~106,000 new cases of colorectal cancer and ~45,000 new cases of rectal cancer would be recorded nationwide in 2022. Although older adults are more prone to develop colorectal cancer, the cases have begun increasing in younger adults. Colectomy, also known as colon resection, is the surgical removal of the diseased part of the intestine or colon. This procedure is recommended for bowel obstruction caused by scar tissue or deformity, bleeding, infection, or ulceration caused by ulcerative colitis, cancer, precancerous polyps, familial polyposis, or traumatic injury.

North America Colorectal Procedure Market Revenue and Forecast to 2028 (US$ Million)

North America Colorectal Procedure Market Segmentation

The North America colorectal procedure market is segmented on the basis of product, surgery type, end user, indication, and country. Based on product, the market is divided into endoscopes, electrosurgery devices, handheld devices and visual systems, sealing and stapling devices, ligation clips and dilators & speculas, cutters and shears, accessories, and others.

In terms of surgery type, the North America colorectal procedure market is segmented into right hemicolectomy, left hemicolectomy, subtotal colectomy, low anterior resection, abdomino-perineal resection, and others (endoscopic surgery).

The North America colorectal procedure market, based on end user, is segmented into hospitals and clinics, surgery centers, and others.

Based on indication, the market is segmented into colon polyps, Crohn's disease, colorectal cancer, colitis, irritable bowel syndrome, and other indications. In terms of country, the North America colorectal procedure market is segmented into the US, Canada, and Mexico. The US has been a dominant market throughout 2022.

B. Braun Melsungen AG; Boston Scientific Corporation; Cardinal Health Inc.; Colospan Ltd; CooperSurgical, Inc.; Ethicon (Johnson & Johnson Services, Inc.); Medtronic; Olympus Corporation; and SAFEHEAL are the leading companies operating in the colorectal procedure market in North America.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America colorectal procedure market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America colorectal procedure market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the colorectal procedure market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution